Technology News and Research

RSS

Seattle Genetics collaborates with Bayer HealthCare for new antibody-drug conjugate

Seattle Genetics, Inc. today announced that it has entered into a new antibody-drug conjugate (ADC) collaboration with Bayer HealthCare (Bayer). Under the latest relationship, Bayer will pay upfront and option exercise fees of up to $20 million for worldwide rights to utilize Seattle Genetics' auristatin-based ADC technology with antibodies to several oncology targets.

25 Jun 2013

New method of maturing human heart cells mimics fetal heart rate

A new method of maturing human heart cells that simulates the natural growth environment of heart cells while applying electrical pulses to mimic the heart rate of fetal humans has led researchers at the University of Toronto to an electrifying step forward for cardiac research.

25 Jun 2013

Promising approach to reduce risk of hypoglycemia in diabetes shows positive results

People with type 1 diabetes who rely on insulin injections to control their blood sugar levels are at risk for life-threatening hypoglycemic events in which their blood glucose levels drop dangerously low.

25 Jun 2013

Study reports catheter ablation is more effective in preventing AFrecurrence

Using catheter ablation to create complete linear lesions around pulmonary veins, proved more effective than the creation of incomplete lesions in preventing recurrence of atrial fibrillation (AF), reports the GAP-AF study.

25 Jun 2013

Newly developed palm-sized microarray platform could enable faster, more efficient drug discovery

A new palm-sized microarray that holds 1,200 individual cultures of fungi or bacteria could enable faster, more efficient drug discovery, according to a study published in mBio-, the online open-access journal of the American Society for Microbiology.

25 Jun 2013

Newly developed approach could benefit basic medical research and help detect H2S in environment

University of Oregon chemists have developed a selective probe that detects hydrogen sulfide (H2S) levels as low as 190 nanomolar (10 parts per billion) in biological samples.

25 Jun 2013

Study suggests adolescents use social networking sites to express suicidal thoughts

Teens and young adults are making use of social networking sites and mobile technology to express suicidal thoughts and intentions as well as to reach out for help, two studies suggest.

25 Jun 2013

Highland Therapeutics subsidiary reports positive HLD-200 Phase-1 results in ADHD patients

Highland Therapeutics, Inc., a specialty pharmaceutical company based in the MaRS Discovery District in Toronto, today announced that its wholly owned subsidiary has generated positive Phase-1 results for HLD-200 - a novel formulation of methylphenidate being developed to treat the symptoms associated with Attention-Deficit/Hyperactivity Disorder.

25 Jun 2013

Tulsa Cancer Institute: The first U.S. center to treat patient with Accuray's TomoHDA System

Accuray Incorporated, announced today that the Tulsa Cancer Institute is the first U.S. center to treat a patient with Accuray's TomoHDA System, the latest and most advanced innovation in the TomoTherapy product lineage designed to treat the full spectrum of cancer patients.

25 Jun 2013

European study to evaluate CardioFocus' HeartLight Endoscopic Ablation System in AF patients

CardioFocus, Inc., developer of the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation, announces that its HeartLight technology is the focus of a multicenter European clinical study for the treatment of drug-refractory persistent AF.

25 Jun 2013

Vocera Communications founder awarded 2013 Jean-Claude Laprie Award in Dependable Computing

Vocera Communications, Inc., the leading provider of solutions that address critical communications and productivity challenges facing healthcare, hospitality, retail and other mobile work environments, today announced that its founder and chief technology officer, Robert Shostak, PhD, has been awarded the 2013 Jean-Claude Laprie Award in Dependable Computing for his co-authored paper, "The Byzantine Generals Problem".

25 Jun 2013

Sentinel lymph node biopsy for early breast cancer: an interview with Prof. Gordon Wishart, Anglia Ruskin University

Our current method, which is recommended by the Association of Breast Surgeons in the UK, involves the use of injections of blue dye and radioisotope to identify the first node(s) under the arm (axilla) called the sentinel nodes.

25 Jun 2013

Thermo Fisher Scientific and Newman-Lakka Institute collaborate to develop new diagnostic approaches for personalized cancer treatment

Thermo Fisher Scientific Inc., the world leader in serving science, and the Newman-Lakka Institute for Personalized Cancer Care at Floating Hospital for Children at Tufts Medical Center, announced an intended collaboration for research and development of new methods to detect and track circulating biomarkers in blood.

25 Jun 2013

MidMichigan Health, UMHS partner to expand access, quality and level of care for patients

MidMichigan Health and the University of Michigan Health System solidified a partnership on Friday, June 21, 2013, when both health care organizations signed an agreement to affiliate.

25 Jun 2013

CytRx reaches targeted enrollment in aldoxorubicin Phase 2b study for treatment of soft tissue sarcoma

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, announced that it has reached the targeted enrollment of 105 evaluable patients in its international Phase 2b clinical trial with aldoxorubicin as a first-line treatment for soft tissue sarcoma.

25 Jun 2013

New method allows assessment of direct stimulation effects on electric activity of human brain

Neuroscientists at the University of Tübingen have become the first to record neuromagnetic activity in the millisecond-by-millisecond range while the brain of a human subject was under stimulation by electric current. Electric brain stimulation has successfully been used in the treatment of neurological and psychiatric disorders for many decades.

24 Jun 2013

Researchers discover reason behind failed anti-cancer therapy

Researchers at the Hebrew University of Jerusalem and in California have achieved a breakthrough in understanding how and why a promising anti-cancer therapy has failed to achieve hoped-for success in killing tumor cells.

24 Jun 2013

Comprehend Systems collaborates with Merge eClinical to expands its clinical research space

Driven by increasing demand for its cloud-based data insights solution, Comprehend Systems further expands its reach in the clinical research space with a partnership with Merge Healthcare's eClinical Solutions division.

21 Jun 2013

Sorrento, IGDRASOL to present updates on IG-001 and IG-004 at joint meeting of CLINAM and ETPN

Sorrento Therapeutics, Inc. and IGDRASOL announced today that the companies will present updates of their analyses of proprietary late clinical stage paclitaxel formulations, IG-001 (Cynviloq) and IG-004 (TOCOSOL paclitaxel) at the joint meeting of the European Foundation for Clinical Nanomedicine and the European Technology Platform on Nanomedicine in Basel, Switzerland on June 23 - 26.

21 Jun 2013

GE Healthcare to acquire certain Mammography assets of Rayence

GE Healthcare today announced that it has agreed to acquire certain Mammography assets of Rayence, a subsidiary of Vatech Co Ltd, a Korean X-Ray manufacturer. The Mammography assets of Rayence will, at closing, become part of the Detection & Guidance Solutions business unit of GE Healthcare.

21 Jun 2013

Technology News and Research

Seattle Genetics collaborates with Bayer HealthCare for new antibody-drug conjugate

New method of maturing human heart cells mimics fetal heart rate

Promising approach to reduce risk of hypoglycemia in diabetes shows positive results

Study reports catheter ablation is more effective in preventing AFrecurrence

Newly developed palm-sized microarray platform could enable faster, more efficient drug discovery

Newly developed approach could benefit basic medical research and help detect H2S in environment

Study suggests adolescents use social networking sites to express suicidal thoughts

Highland Therapeutics subsidiary reports positive HLD-200 Phase-1 results in ADHD patients

Tulsa Cancer Institute: The first U.S. center to treat patient with Accuray's TomoHDA System

European study to evaluate CardioFocus' HeartLight Endoscopic Ablation System in AF patients

Vocera Communications founder awarded 2013 Jean-Claude Laprie Award in Dependable Computing

Sentinel lymph node biopsy for early breast cancer: an interview with Prof. Gordon Wishart, Anglia Ruskin University

Thermo Fisher Scientific and Newman-Lakka Institute collaborate to develop new diagnostic approaches for personalized cancer treatment

MidMichigan Health, UMHS partner to expand access, quality and level of care for patients

CytRx reaches targeted enrollment in aldoxorubicin Phase 2b study for treatment of soft tissue sarcoma

New method allows assessment of direct stimulation effects on electric activity of human brain

Researchers discover reason behind failed anti-cancer therapy

Comprehend Systems collaborates with Merge eClinical to expands its clinical research space

Sorrento, IGDRASOL to present updates on IG-001 and IG-004 at joint meeting of CLINAM and ETPN

GE Healthcare to acquire certain Mammography assets of Rayence

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News